Nakatsuka M, Yoshida N, Kudo T
Department of Obstetrics and Gynaecology, Okayama University Medical School, Japan.
Hum Reprod. 1992 Nov;7(10):1435-9. doi: 10.1093/oxfordjournals.humrep.a137590.
Although human chorionic gonadotrophin can detect trophoblast after implantation of the conceptus, there is a need to detect the conceptus before implantation. We have investigated whether human embryo-derived platelet activating factor is formed during embryonic development after in-vitro fertilization. A total of 99 ova from 12 patients were cultured and the 54 media were analysed. Platelet activating factor was also measured by radioimmunoassay after extraction. Fertilization increased the amount of platelet activating factor 4-fold over non-fertilized ova to a level of 4 ng/ml. This increase was also dependent on the degree of embryonic development with a maximum level of platelet activating factor of 7 ng/ml at the 2-cell stage. The follicular inducing agent used to treat the patient also had an effect on platelet activating factor; buserelin treatment gave embryos with a higher level than did clomiphene citrate treatment. These results indicate that platelet activating factor may have a role in embryonic development before implantation and may serve as a useful marker for fertilization and the developmental stage of the embryo.
尽管人绒毛膜促性腺激素能够在孕体着床后检测到滋养层,但仍需要在着床前检测到孕体。我们研究了体外受精后胚胎发育过程中是否会形成人胚胎源性血小板活化因子。对12名患者的99个卵子进行培养,并对54份培养基进行分析。提取后还用放射免疫分析法测定了血小板活化因子。受精使血小板活化因子的量比未受精卵增加了4倍,达到4纳克/毫升的水平。这种增加也取决于胚胎发育程度,在2细胞阶段血小板活化因子的最高水平为7纳克/毫升。用于治疗患者的促卵泡剂对血小板活化因子也有影响;布舍瑞林治疗组的胚胎血小板活化因子水平高于枸橼酸氯米芬治疗组。这些结果表明,血小板活化因子可能在着床前的胚胎发育中起作用,并且可能作为受精和胚胎发育阶段的有用标志物。